OTCMKTS:INBP Integrated BioPharma (INBP) Stock Price, News & Analysis $0.30 -0.04 (-10.74%) As of 03:34 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsSEC FilingsShort InterestBuy This Stock About Integrated BioPharma Stock (OTCMKTS:INBP) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Integrated BioPharma alerts:Sign Up Key Stats Today's Range$0.28▼$0.3250-Day Range$0.26▼$0.3552-Week Range$0.16▼$0.42Volume24,748 shsAverage Volume21,940 shsMarket Capitalization$9.20 millionP/E Ratio10.12Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewIntegrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.Read More… Receive INBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Integrated BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address INBP Stock News HeadlinesIntegrated BioPharma Secures New Credit Line with PNCApril 21, 2025 | tipranks.comIntegrated Biopharma Inc (INBP)September 1, 2024 | investing.comTrump Quietly Planning $15 Trillion Crypto ShockerMost investors are still unaware, but I believe a new White House action may have quietly opened the floodgates for a $15 trillion crypto surge. My latest crypto playbook reveals the coin I’m most bullish on—including the name, ticker, and why I’m investing personal capital into it.May 28, 2025 | Paradigm Press (Ad)Integrated BioPharma, Inc. (INBP)July 19, 2024 | finance.yahoo.comIntegrated BioPharma Reports Results for its Quarter Ended December 31, 2023February 12, 2024 | finance.yahoo.comKBI Biopharma and Argonaut form drug manufacturing allianceJanuary 17, 2024 | msn.comKBI Biopharma, Inc. and Argonaut Manufacturing Services, Inc. Forge Strategic Alliance to Support Global Biopharmaceutical Companies with Integrated Drug Substance and Drug ...January 16, 2024 | businesswire.comJohnson & Johnson buys San Diego's Ambrx Biopharma for $2BJanuary 9, 2024 | msn.comSee More Headlines INBP Stock Analysis - Frequently Asked Questions How have INBP shares performed this year? Integrated BioPharma's stock was trading at $0.3297 at the start of the year. Since then, INBP shares have decreased by 7.9% and is now trading at $0.3035. View the best growth stocks for 2025 here. How were Integrated BioPharma's earnings last quarter? Integrated BioPharma, Inc. (OTCMKTS:INBP) announced its quarterly earnings data on Wednesday, May, 14th. The company reported $0.02 earnings per share (EPS) for the quarter. The business had revenue of $13.95 million for the quarter. Integrated BioPharma had a trailing twelve-month return on equity of 4.79% and a net margin of 1.78%. How do I buy shares of Integrated BioPharma? Shares of INBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Integrated BioPharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that Integrated BioPharma investors own include GSK (GSK), Invitae (NVTA), Exxon Mobil (XOM), Autodesk (ADSK), Adaptive Biotechnologies (ADPT), Analog Devices (ADI) and Adaptimmune Therapeutics (ADAP). Company Calendar Last Earnings5/14/2025Today5/28/2025Fiscal Year End6/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:INBP CIK1016504 Webwww.integratedbiopharma.com Phone(973) 926-0816Fax973-926-1735Employees150Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.04 Trailing P/E Ratio11.34 Forward P/E RatioN/A P/E GrowthN/ANet Income$110 thousand Net Margins1.78% Pretax Margin2.79% Return on Equity4.79% Return on Assets3.54% Debt Debt-to-Equity RatioN/A Current Ratio3.26 Quick Ratio1.27 Sales & Book Value Annual Sales$50.32 million Price / Sales0.20 Cash Flow$0.05 per share Price / Cash Flow7.35 Book Value$0.65 per share Price / Book0.52Miscellaneous Outstanding Shares30,301,000Free Float9,939,000Market Cap$10.30 million OptionableNot Optionable Beta0.80 Social Links Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report This page (OTCMKTS:INBP) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored“You all just got a lot richer”Trump Knows What He’s Doing. When the president says he’s going to let RFK “go wild” … and Big Pharma crash...Brownstone Research | SponsoredUrgent: Make this trade before you hit your pillow tonight… Most people waste 8 hours every night… And 227,916 hours in their lifetime… Dreaming about the life they...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integrated BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Integrated BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.